This intellectual property portfolio encompasses a broad range of innovative technologies targeting infectious diseases and their diagnosis. The portfolio includes cutting-edge vaccine development platforms, novel antibiotics and antivirals, as well as advanced diagnostic and prognostic tools. These inventions aim to address the global challenges posed by infectious diseases, including the COVID-19 pandemic, by providing more effective prevention, treatment, and detection strategies.
This collection features inventions from Stanford's pioneering researchers such as Ronald Levy, Rhiju Das, Bali Pulendran, Peter Kim, Jeffrey Glenn, Irving Weissman, Jennifer Dionne, and Maria Barna.